Clinverse, Inc. Announces Strategic Partnership with Datatrak
Clinverse, Inc. announced today that it has formed a strategic partnership with Datatrak
Clinverse, Inc., provider of the first end-to-end technology solution that automates the financial lifecycle of global clinical trials, announced today that it has formed a strategic partnership with Datatrak, a leader in developing cloud-based, unified eClinical® technologies.
Clinverse’s ClinPay® solution automates sponsor payments to clinical vendors, investigators, and other parties throughout the entire financial lifecycle of a clinical trial. The Datatrak ONE® solution allows sponsors and CROs to obtain higher quality data faster with user-friendly and powerful tools.
By integrating existing clinical systems with ClinPay, sponsors and CROs can further streamline the payment process and reduce workload, time, and related costs. For example, Datatrak ’s uEDC™ can seamlessly integrate into ClinPay so that payments are triggered based on actual data entered into the EDC system. Clinverse’s open application programming interface (API) allows for integration with any existing systems. This combination optimizes cost savings by streamlining an inherently error-prone manual process and substantially reduces labor costs associated with the payment and accounting process for clinical vendors and investigative sites.
“Clinverse and Datatrak share common goals, focused on reducing complexity and costs typically associated with clinical trials,” said Laurence P. Birch, Datatrak Chairman of the Board and CEO. “Working together, Datatrak ONE and ClinPay seamlessly integrate, automating payments based on real-time data. Streamlining the payment process delivers enhanced data quality, trial safety, and efficiency for our partners, leveraging the most efficient financial tool on the market.”
“Datatrak is an ideal partner for our solutions,” said Jeff Rogers, Chief Commercial Officer of Clinverse. “The many benefits of ClinPay can be realized in a true real-time single database architecture, which Datatrak delivers. Our expertise in global currencies and trials reduces complexity and enhances efficiencies for all trial phases.”
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
